Test Discontinuation Memorandum

Effective August 31 2016, in a continuing effort to optimize our offerings, these changes will be made.

The following will be discontinued:

  • Alpha-Galactosidase A Enzyme Analysis on skin fibroblasts (TC 4516)
  • Alpha-Galactosidase A Enzyme Analysis on WBC (TC 4517)
  • Arylsulfatase A Enzyme Analysis on skin fibroblasts (TC 4537)
  • Arylsulfatase A Enzyme Analysis on WBC (TC 4538)
  • Beta-Glucosidase Enzyme Analysis on skin fibroblasts (TC 4553)
  • Beta-Glucosidase Enzyme Analysis on WBC (TC 4554)
  • Citrulline Incorporation into Protein on amniotic fluid (TC 4558)
  • Citrulline Incorporation into Protein on CVS (TC 4559)
  • Citrulline Incorporation into Protein on skin fibroblasts (TC 4560)
  • Galactocerebrosidase Enzyme Analysis on skin fibroblasts (TC 4565)
  • Galactocerebrosidase Enzyme Analysis on WBC (TC 4566)
  • Alpha-L-iduronidase Enzyme Analysis on skin fibroblasts (TC 4575)
  • Alpha-L-iduronidase Enzyme Analysis on WBC (TC 4576)
  • Sphingomyelinase Enzyme Assay on skin fibroblasts (TC 4607)
  • Sphingomyelinase Enzyme Assay on WBC (TC 4608)

For the Citrulline Incorporation into Protein on amniotic fluid, an alternative test is available:

  • Amniotic Fluid Amino Acid Analysis (TC 4170). Please contact us to obtain more information about this test.
Previous Post
Test Discontinuations Memorandum – Mitochondrial
Next Post
Test Discontinuation Memorandum
Menu